Pancreatic Exocrine Cancer Symptoms Drug Treatment

Pancreatic Carcinoma is cancer of the pancreas. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. Pancreatic cancer is also called Exocrine Cancer. A tumor or cancer in the pancreas may often grow without any symptoms at first. This may mean pancreatic cancer is more advanced when it is first found. Each year in the United States, about 42470 individuals are diagnosed with this condition.

Tweet-for-Cash with SponsoredTweets

Pancreatic Cancer Research ranges from epidemiology, molecular bioscience to the performance of clinical trials to evaluate and compare applications of the various cancer treatment. These applications include surgery, radiation therapy, chemotherapy and hormone therapy, and combined treatment modalities such as chemo-radiotherapy. Starting in the mid-1990s, the emphasis in clinical cancer research shifted towards therapies derived from biotechnology research, such as immunotherapy and gene therapy.

While there has been most welcome steady progress with the diagnosis and treatment of several other forms of cancer, for pancreatic cancer the five-year survival rate in this country following diagnosis forty years ago stood at around 3%.

Today that rate is virtually unchanged and for many sufferers the survival time from diagnosis of the cancer is very short and complete remission is extremely rare. While pancreatic cancer is the eleventh most common cancer it is the fourth most common cause of death from cancer.

Pancreatic cancer causes few obvious symptoms early on and detection is therefore usually at a late stage in the progression of the illness. The median survival rate from diagnosis is just 3 - 6 months with only 15% surviving for a year. Affecting men and women more or less equally, pancreatic cancer has one of the highest fatality rates of all cancers - 97% over five years as we have seen. Yet the disease can be tackled on those occasions where the cancer, for one reason or another, happens to be detected early enough. Pancreatic cancer should be ranked higher in the list of national priorities.

---

---

New York judge with cancer makes case for marijuana

NEW YORK (Reuters) - A cancer-stricken judge in New York has become an unlikely voice in support of legalizing the use of medical marijuana with the admission that he smokes pot to ease the side-effects of his treatments. Brooklyn Supreme Court Justice Gustin Reichbach, who is being treated for pancreatic cancer, wrote in a New York Times article on Thursday that he had been using marijuana ...

Biomarker Found for Pancreatic Cancer

Scientists at the University of California at San Diego School of Medicine have identified a new biomarker for pancreatic cancer. The finding helps researchers move one step forward in creating therapeutic treatments for the potentially deadly disease.

Early biomarker for pancreatic cancer identified

( University of California - San Diego ) Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.

Pancreatic cancer survivor raises awareness

As a six-year survivor of pancreatic cancer, Diane Borrison knows she's in a select group. Pancreatic cancer is the fourth-leading cause of cancer deaths, it has the lowest survival rate of all cancers and only 6...

Pancreatic cancer research topic of Campbell meeting

The Silicon Valley affiliate of the Pancreatic Cancer Action Network will hold a meeting on May 22 at the Campbell Library to discuss volunteer opportunities.

Commercializing Pancreatic Cancer Drugs: The Faster Route to Consider Your Options and Position of Others

NEW YORK, May 10, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Commercializing Pancreatic Cancer Drugs: The Faster Route to Consider ...

Triple Analysis: Lung Cancer, Pancreatic Cancer and Peptides

NEW YORK, May 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:  Triple Analysis: Lung Cancer, Pancreatic Cancer and Peptides http://www.reportlinker.com/p0284632/Triple-Analysis-Lung-Cancer-Pancreatic-Cancer-and-Peptides.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology This ...

BSD Medical Reports Hyperthermia Clinical Study on Pancreatic Cancer Highlighted at Society of Thermal Medicine ...

BSD Medical Corporation , a leading provider of medical systems that utilize heat therapy to treat cancer, reported today that an important Phase III clinical study, hyperthermia in combination with chemotherapy for the treatment of pancreatic cancer patients, was the subject of a press release issued by The Society of Thermal Medicine .

What is pancreatic cancer?

Pancreatic cancer -- the fourth leading cause of cancer death in the United States -- occurs when malignant cells develop in the pancreas. The National Cancer Institute estimated that in 2012, approximately 43,920 people will be diagnosed with pancreatic cancer, and 37,390 people will die from the disease. Within the first year of diagnosis, 75 percent of pancreatic cancer patients die ...

Pancreatic Cancer - Drug May Target Faulty Gene In 15% Of Patients

A new class of cancer drug which targets a faulty gene might be effective in treating some aggressive pancreatic cancers, researchers from Cancer Research UK's Cambridge Research Institute and the Wellcome Trust Sanger Institute reported in the journal Nature. Pancreatic cancer kills approximately 37,000 people in the USA and 8,000 in the UK every year. Even though survival rates have been ...

Source: